Amgen (NASDAQ:AMGN) is a biotechnology pioneer, focused on researching and manufacturing innovative human therapeutics. Amgen's operations span globally, with a significant emphasis on areas such as oncology, cardiovascular disease, bone health, neuroscience, nephrology, and inflammation. The company's projects often involve developing biologic medications aimed at treating serious illnesses and improving the quality of life for patients worldwide. Amgen's objectives include pushing the boundaries of science to transform medicine, ensuring the sustainability of their business practices, and expanding their market presence through strategic collaborations and acquisitions. The company is dedicated to addressing the unmet medical needs of patients through continual innovation and comprehensive healthcare solutions.